Project description
Nuclear magnetic resonance makes a mark on fertility treatment
The success of in vitro fertilisation largely relies on selecting the embryo with the highest likelihood of developing into a healthy baby. This remains a challenge for doctors, who count on insufficient or costly methods such as microscope examination or biopsy, respectively. With a small percentage of IVF attempts resulting in a successful pregnancy, there is a need for superior screening options. Supported by the EU-funded Embryospin project, Annaida Technologies have developed a novel solution for fast and non-invasive embryo screening: a ground-breaking device that performs microscopic nuclear magnetic resonance at a scale 10 times better than existing technologies and can provide results for up to 10 embryos in one hour. The technique is set to increase the success of the fertility treatment while also cutting costs for the couples undergoing IVF.
Fields of science
- natural scienceschemical sciencesanalytical chemistryquantitative analysis
- medical and health sciencesclinical medicinegynaecologyreproductive medicine
- natural sciencesphysical sciencesopticsmicroscopy
- medical and health sciencesclinical medicineobstetrics
- medical and health sciencesclinical medicineembryology
Programme(s)
Funding Scheme
SME-1 - SME instrument phase 1Coordinator
1003 Lausanne
Switzerland
See on map